journal article·2019-12-04Open access

Swainsonine inhibits proliferation and collagen synthesis of NIH-3T3 cells by declining miR-21

Chao Li, Peipei Wang, Ziyang Fu, Yongtao Li, Shouju Li

Abstract

Swainsonine (SW) is an indolizidine alkaloid first discovered in Swainsona canescens. This study explored the effects of SW on mouse embryo fibroblast NIH-3T3 cell proliferation and collagen synthesis, as well as potential molecule mechanisms. We discovered that SW exposure lowered the viability and proliferation of NIH-3T3 cells. The collagen synthesis was reduced after SW exposure, as evidenced by declines of the mRNA and protein levels of collagen I (CoI I), collagen III (CoI III) and α-smooth muscle actin (α-SMA) in NIH-3T3 cells, as well as reduction of collagen concentration in the culture supernatant of NIH-3T3 cells. Mechanically, transforming growth factor β1 (TGF-β1) stimulation elevated the microRNA-21 (miR-21) expression in NIH-3T3 cells. SW reversed the TGF-β1-caused elevation of miR-21. Up-regulation of miR-21 attenuated the inhibitory influences of SW on NIH-3T3 cell viability, proliferation and collagen synthesis. Silence of miR-21 had converse influence. Besides, SW inactivated PI3K/AKT and NF-κB pathways via declining miR-21. Altogether, SW inhibited the proliferation and collagen synthesis of fibroblast NIH-3T3 might be through declining miR-21 and then suppressing PI3K/AKT and NF-κB pathways. SW may be an effective therapeutic medicine for scar hyperplasia.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: MicroRNA in disease regulation · Microbial Applications in Construction Materials · Developmental Biology and Gene Regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Burn and Plastic Surgery, Heze Municipal Hospital

References (37)

Show source-provided references
1. 10.1111/ijd.1243610.1111/ijd.12436 ↗
2. 10.1111/wrr.1244210.1111/wrr.12442 ↗
3. 10.3892/mmr.2017.677910.3892/mmr.2017.6779 ↗
4. 10.1111/iwj.1228310.1111/iwj.12283 ↗
5. 10.1016/j.bbrc.2017.11.02710.1016/j.bbrc.2017.11.027 ↗
6. 10.1021/jf501674r10.1021/jf501674r ↗
7. 10.4014/jmb.1709.0900310.4014/jmb.1709.09003 ↗
8. 10.1016/j.etap.2016.08.01810.1016/j.etap.2016.08.018 ↗
9. 10.1002/jcb.24021020210.1002/jcb.240210202 ↗
10. 10.1016/0003-9861(88)90327-X10.1016/0003-9861(88)90327-X ↗
11. 10.1016/j.addr.2015.05.00110.1016/j.addr.2015.05.001 ↗
12. 10.3390/ijms1710171210.3390/ijms17101712 ↗
13. 10.1016/j.critrevonc.2017.05.00810.1016/j.critrevonc.2017.05.008 ↗
14. 10.1016/j.biopha.2017.11.00310.1016/j.biopha.2017.11.003 ↗
15. 10.1016/j.yexcr.2015.10.01810.1016/j.yexcr.2015.10.018 ↗
16. 10.1016/j.yexcr.2016.05.01310.1016/j.yexcr.2016.05.013 ↗
17. 10.1038/srep3223110.1038/srep32231 ↗
18. 10.1016/j.biopha.2017.03.04410.1016/j.biopha.2017.03.044 ↗
19. Grande J, Melder D, Zinsmeister A, et al. Transforming growth factor-beta 1 induces collagen IV gene expression in NIH-3T3 cells. Lab Invest. 1993;69:387–395.
20. 10.1007/978-1-60761-611-5_710.1007/978-1-60761-611-5_7 ↗
21. 10.1590/1414-431x2018766510.1590/1414-431x20187665 ↗
22. 10.1542/peds.2014-206510.1542/peds.2014-2065 ↗
23. 10.6061/clinics/2014(08)1110.6061/clinics/2014(08)11 ↗
24. 10.12659/MSM.89822110.12659/MSM.898221 ↗
25. 10.1016/j.lfs.2016.07.01110.1016/j.lfs.2016.07.011 ↗
26. Mi L, Li YY, Lin WH, et al. The effect of integrin-linked kinase on VEGF expression in fibroblasts from human hypertrophic scar. Zhonghua Zheng Xing Wai ke za Zhi = Zhonghua Zhengxing Waike Zazhi = Chin J Plastic Surg. 2011;27:289–293.
27. 10.1242/dev.09174410.1242/dev.091744 ↗
28. 10.1038/cdd.2017.17410.1038/cdd.2017.174 ↗
29. 10.1007/s40139-014-0047-x10.1007/s40139-014-0047-x ↗
30. 10.1007/s12015-018-9808-y10.1007/s12015-018-9808-y ↗
31. 10.1007/978-1-4939-6524-3_110.1007/978-1-4939-6524-3_1 ↗
32. Wang BB, Xie H, Wu T, et al. Controlled-release mitomycin C-polylactic acid film prevents epidural scar hyperplasia after laminectomy by inducing fibroblast autophagy and regulating the expression of miRNAs. Eur Rev Med Pharmacol Sci. 2017;21:2526–2537.
33. 10.1007/s10103-016-1898-710.1007/s10103-016-1898-7 ↗
34. 10.1007/s11033-012-1671-310.1007/s11033-012-1671-3 ↗
35. 10.1242/dev.13707510.1242/dev.137075 ↗
36. 10.3892/ijmm.2014.176010.3892/ijmm.2014.1760 ↗
37. 10.1371/journal.pone.007188710.1371/journal.pone.0071887 ↗